Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors
Alam, M., Beevers, R.E., Ceska, T., Davenport, R.J., Dickson, K.M., Fortunato, M., Gowers, L., Haughan, A.F., James, L.A., Jones, M.W., Kinsella, N., Lowe, C., Meissner, J.W., Nicolas, A.L., Perry, B.G., Phillips, D.J., Pitt, W.R., Platt, A., Ratcliffe, A.J., Sharpe, A., Tait, L.J.(2007) Bioorg Med Chem Lett 17: 3463-3467
- PubMed: 17459703 
- DOI: https://doi.org/10.1016/j.bmcl.2007.03.078
- Primary Citation of Related Structures:  
2P33 - PubMed Abstract: 
The development of a series of novel aminopyrimidines as inhibitors of c-Jun N-terminal kinases is described. The synthesis, in vitro inhibitory values for JNK1, JNK2 and CDK2, and the in vitro inhibitory value for a c-Jun cellular assay are discussed.
Organizational Affiliation: 
UCB, Granta Park, Great Abington, Cambridge CB21 6GS, UK.